Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
1,035
+27
+3% +$9.24K 0.1% 93
2026
Q1
$355K Buy
1,008
+27
+3% +$9.63K 0.1% 92
2025
Q4
$321K Buy
981
+71
+8% +$22.5K 0.09% 91
2025
Q3
$257K Buy
910
+35
+4% +$10.2K 0.08% 100
2025
Q2
$244K Buy
875
+26
+3% +$7.37K 0.09% 95
2025
Q1
$265K Buy
849
+45
+6% +$13.3K 0.14% 77
2024
Q4
$210K Sell
804
-38
-5% -$11.3K 0.09% 107
2024
Q3
$271K Buy
842
+2
+0.2% +$654 0.12% 91
2024
Q2
$262K Buy
840
+11
+1% +$3.23K 0.13% 85
2024
Q1
$236K Buy
829
+45
+6% +$13.2K 0.12% 90
2023
Q4
$226K Buy
+784
New +$214K 0.14% 82

Other funds holding AMGN

Crown Wealth Group's AMGN Position: Q2 2026 in Review

Crown Wealth Group increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $9.24K and bringing the position to 1,035 shares worth $375K. The position accounts for 0.1% of the portfolio, ranked #93.

Crown Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Crown Wealth Group held 1,035 shares of Amgen worth $375K as of Q2 2026.
  • Crown Wealth Group bought 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.1% of Crown Wealth Group's portfolio in Q2 2026, its #93 holding.
  • Crown Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Crown Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.